Celcuity (CELC) Net Cash Flow (2016 - 2025)
Celcuity's (CELC) quarterly Net Cash Flow came in at $91.5 million in Q4 2025, up 822.63% YoY from $9.9 million in Q4 2024, and up 227.8% on a QoQ basis from $27.9 million in Q3 2025.
Celcuity (CELC) Net Cash Flow (2016 - 2025) Analysis & Trends
Celcuity (CELC) has 10 years of Net Cash Flow data on file, last reported at $91.5 million in Q4 2025.
- Quarterly Net Cash Flow rose 822.63% year-over-year to $91.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $143.2 million (up 1857.34% YoY) and the FY2025 annual result came in at $143.2 million, up 1857.34% from the prior year.
- Net Cash Flow rose to $91.5 million in Q4 2025, from $27.9 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $91.5 million in Q4 2025 to a low of -$32.9 million in Q4 2022.
- A 5-year average of $7.7 million and a median of -$102000.0 in 2024 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 4051.85% in 2025, down 1193.66% in 2025.
- Tracing CELC's Net Cash Flow over 5 years: stood at -$6.1 million in 2021, then slumped by 441.28% to -$32.9 million in 2022, then jumped by 114.9% to $4.9 million in 2023, then soared by 102.17% to $9.9 million in 2024, then surged by 822.63% to $91.5 million in 2025.
- The last three Net Cash Flow figures came in at $91.5 million (Q4 2025), $27.9 million (Q3 2025), and $29.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91.45 Mn |
| Dec 31, 2025 | 91.45 Mn |
| Sep 30, 2025 | 27.90 Mn |
| Sep 30, 2025 | 27.90 Mn |
| Jun 30, 2025 | 29.88 Mn |
| Jun 30, 2025 | 29.88 Mn |
| Mar 31, 2025 | -6.04 Mn |
| Mar 31, 2025 | -6.04 Mn |
| Dec 31, 2024 | 9.91 Mn |
| Dec 31, 2024 | 9.91 Mn |
| Sep 30, 2024 | -17.86 Mn |
| Sep 30, 2024 | -17.86 Mn |
| Jun 30, 2024 | -756,000.00 |
| Jun 30, 2024 | -756,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Dec 31, 2023 | 4.90 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Sep 30, 2023 | -6.48 Mn |
| Sep 30, 2023 | -6.48 Mn |